Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Antibacterials, antimycobacterials and antimycotics for systemic use, part 2" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in seven (7) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Ertapenem 1 g (1 g powder for i.v. / vial, ATC J01DH03) LOT 2: Cefiderocol 1 g (1 g powder for i.v. / vial, ATC J01DI04) LOT 3: Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01) LOT 4: Levofloxacin 5 mg/ml (100 ml, i.v. solution, ATC J01MA12) LOT 5: Ceftriaxone natrium 2 g (2 g powder for i.v. / vial, ATC J01DD04) LOT 6: Fluconazole 2 mg/ml (100 ml, i.v. solution, ATC J02AC01) LOT 7: Rifampicin 300 mg or 600 mg (tablet/capsule, oral, ATC J04AB02) The minimum requirements for the products is described in Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Description of the rotation Annex 2.1 Quality scoring table Annex 3 Contract Annex 4 Security annex Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Confidentiality commitment Annex 7 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.
Määräaika
Tarjousten vastaanottamisen määräaika oli 2025-02-05.
Hankinta julkaistiin 2024-12-18.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
hankintailmoitus (2024-12-18) Kohde Hankinnan laajuus
Otsikko: Antibacterials, antimycobacterials and antimycotics for systemic use, part 2
Viitenumero: THL/5789/2.02.06/2024
Lyhyt kuvaus:
“Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Antibacterials, antimycobacterials and antimycotics...”
Lyhyt kuvaus
Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Antibacterials, antimycobacterials and antimycotics for systemic use, part 2" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1.
The procurement is divided in seven (7) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots.
LOT 1: Ertapenem 1 g (1 g powder for i.v. / vial, ATC J01DH03)
LOT 2: Cefiderocol 1 g (1 g powder for i.v. / vial, ATC J01DI04)
LOT 3: Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01)
LOT 4: Levofloxacin 5 mg/ml (100 ml, i.v. solution, ATC J01MA12)
LOT 5: Ceftriaxone natrium 2 g (2 g powder for i.v. / vial, ATC J01DD04)
LOT 6: Fluconazole 2 mg/ml (100 ml, i.v. solution, ATC J02AC01)
LOT 7: Rifampicin 300 mg or 600 mg (tablet/capsule, oral, ATC J04AB02)
The minimum requirements for the products is described in Annex 1.1.
The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed.
Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option.
Please note that all times given in the Call for tenders refer to local time in Finland.
Call for tenders, Annexes:
Annex 1 Scope of the procurement
Annex 1.1 Minimum requirements
Annex 2 Description of the rotation
Annex 2.1 Quality scoring table
Annex 3 Contract
Annex 4 Security annex
Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022)
Annex 6 Confidentiality commitment
Annex 7 Quantity of the Articles (restricted, TL IV)
Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.
Näytä lisää
Sopimustyyppi: Tavarat
Tuotteet/palvelut: Systeemisesti vaikuttavat infektiolääkkeet📦
Suorituspaikkaa koskevat rajoitukset: Missä tahansa tietyn maan alueella
Tietoa eristä
Tämä sopimus on jaettu osiin ✅
Yhdelle tarjoajalle myönnettävien erien enimmäismäärä: 7
Tarjouksia voidaan jättää enintään yhtä erää varten: 7
1️⃣
Sisäinen tunniste: 1
Otsikko: LOT 1: Ertapenem 1 g (1 g powder for i.v. / vial, ATC J01DH03)
Tämä hankinta soveltuu myös pienille ja keskisuurille yrityksille (pk-yrityksille) ✅
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Ertapenem 1 g (1 g powder for i.v. /...”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Ertapenem 1 g (1 g powder for i.v. / vial, ATC J01DH03)
- Parenteral products (intravenous administration)
- Active pharmaceutical ingredient: Ertapenem
- Pharmaceutical form: 1 g powder for i.v. / vial
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Näytä lisää
Lisätietoja:
“The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer...”
Lisätietoja
The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 6). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/5789/2.02.06/2024 / Antibacterials, antimycobacterials and antimycotics for systemic use, part 2". The message shall contain name of the tenderer and email address to which the Annex 7 is to be sent.
Näytä lisää
Sopimustyyppi: Tavarat
Tuotteet/palvelut: Systeemiset bakteerilääkkeet📦
Maa: Suomi 🇫🇮
Kesto: 20 (MONTH)
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Tietoa vaihtoehdoista
Vaihtoehdot ✅
Vaihtoehtojen kuvaus:
“In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities...”
Vaihtoehtojen kuvaus
In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
Näytä lisää Myöntämisperusteet
Hinta ✅
Hinta (painotus): 50
Laatukriteeri (nimi): Quality 1: Registered shelf life of the Article
Laatukriteeri (painotus): 10
Laatukriteeri (nimi): Quality 2: Delivery time to the Customer’s warehouse
Laatukriteeri (painotus): 15
Laatukriteeri (nimi): Quality 3: Transportation temperature and excursions
Laatukriteeri (painotus): 3
Laatukriteeri (nimi): Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging
Quality 5: Rotation plan for the Article
Laatukriteeri (painotus): 12
Otsikko
Erän tunnistenumero: LOT-0001
2️⃣
Sisäinen tunniste: 2
Otsikko: LOT 2: Cefiderocol 1 g (1 g powder for i.v. / vial, ATC J01DI04)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Cefiderocol 1 g (1 g powder for i.v. /...”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Cefiderocol 1 g (1 g powder for i.v. / vial, ATC J01DI04)
- Parenteral products (intravenous administration)
- Active pharmaceutical ingredient: Cefiderocol
- Pharmaceutical form: 1 g powder for i.v. / vial
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
3️⃣
Sisäinen tunniste: 3
Otsikko: LOT 3: Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Clindamycin 150 mg/ml (4 ml per...”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01)
- Parenteral products (intravenous administration)
- Active pharmaceutical ingredient: Clindamycin
- Strength: 150 mg/ml
- Pharmaceutical form: 4 ml i.v., per vial/ampoule
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
4️⃣
Sisäinen tunniste: 4
Otsikko: LOT 4: Levofloxacin 5 mg/ml (100 ml, i.v. solution, ATC J01MA12)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Levofloxacin 5 mg/ml (100 ml, i.v....”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Näytä lisää
Lisätietoja:
“The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer...”
Lisätietoja
The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 6). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/5789/2.02.06/2024 Antibacterials, antimycobacterials and antimycotics for systemic use, part 2". The message shall contain name of the tenderer and email address to which the Annex 7 is to be sent.
5️⃣
Sisäinen tunniste: 5
Otsikko: LOT 5: Ceftriaxone natrium 2 g (2 g powder for i.v. / vial, ATC J01DD04)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Ceftriaxone natrium 2 g (2 g powder for...”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Ceftriaxone natrium 2 g (2 g powder for i.v. / vial, ATC J01DD04)
- Parenteral products (intravenous administration)
- Active pharmaceutical ingredient: Ceftriaxone natrium
- Pharmaceutical form: 2 g powder for i.v. / vial
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
6️⃣
Sisäinen tunniste: 6
Otsikko: LOT 6: Fluconazole 2 mg/ml (100 ml, i.v. solution, ATC J02AC01)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Fluconazole 2 mg/ml (100 ml, i.v....”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
7️⃣
Sisäinen tunniste: 7
Otsikko: LOT 7: Rifampicin 300 mg or 600 mg (tablet/capsule, oral, ATC J04AB02)
Hankinnan kuvaus:
“The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Rifampicin 300 mg or 600 mg...”
Hankinnan kuvaus
The subject of the procurement is Article in accordance with the following requirements:
- The subject of tender: Rifampicin 300 mg or 600 mg (tablet/capsule, oral, ATC J04AB02)
- Oral solid dosage forms
- Active pharmaceutical ingredient: Rifampicin
- Strength: 300 mg or 600 mg
- Pharmaceutical form: tablet/capsule
The minimum requirements of the Article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
The tender shall consist of one (1) Article: either of 300 mg or 600 mg tablet/capsule.
The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Menettely Toimenpiteen tyyppi
Avoin menettely ✅
Oikeusperusta: Direktiivi 2014/24/EU
Menettelyn tärkeimmät piirteet:
“Tenders must be submitted electronically via the Cloudia Supplier Portal. It is the responsibility of the tenderer to submit the tender by the deadline. No...”
Menettelyn tärkeimmät piirteet
Tenders must be submitted electronically via the Cloudia Supplier Portal. It is the responsibility of the tenderer to submit the tender by the deadline. No compensation will be paid for submitting a tender.
Requirements concerning tenderers and the Article, as well as eventual reports and explanations required in the tender, are described in this Call for tenders.
All the attachments mentioned in the Call for tenders should be sent with the tender. The tender must be submitted in writing, in English. Also, the annexes and all related material or correspondence must be in English.
The process steps are:
1. Opening the tenders.
2. Inspecting the suitability of tenderers according to the ESPD form.
3. Inspecting that tenders meet the requirements set in the Call for tenders.
4. Comparison of tenders.
5. Making and announcing the Procurement decision.
6. Verifying the information given by the awarded tenderer on the ESPD form.
7. Background check by asking the winning tenderer to submit criminal record exctracts.
8. Drafting the Contract. The Contract is only valid after a written Contract is signed.
The Contract can be signed no earlier than 14 days from the time the tenderer has been informed, or is considered to have been informed, of the Procurement decision and its grounds (= stand-still period).
Näytä lisää Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2025-02-05 10:00:00 📅
Tarjousten avaamista koskevat ehdot: 2025-02-05 10:30:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Tarjouspyynnön ehdot
Tarjoaja voi jättää useamman kuin yhden tarjouksen
Tarjousten avaamisen päivämäärä: 2025-02-05 10:30:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Sähköinen laskutus: Sallittu
Sähköistä maksua käytetään ✅
Lisätietojen pyytämisen määräaika: 2025-01-22 10:00:00 📅
Myöntämisperusteet
Painotustyyppi: Painotus (pisteinä, tarkka)
Tarjouspyynnön ehdot
Sopimukseen sisältyy suoritusehtoja ✅
Salassapitosopimus on pakollinen ✅
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Taloudellinen ja rahoituksellinen asema
Luettelo ja lyhyt kuvaus valintaperusteista:
“Yearly turnover: The tenderer´s financial prerequisites are sufficient with regard to the size and nature of the procurement. In order that the tenderer may...”
Luettelo ja lyhyt kuvaus valintaperusteista
Yearly turnover: The tenderer´s financial prerequisites are sufficient with regard to the size and nature of the procurement. In order that the tenderer may be estimated to be able to provide and deliver the Articles subject to procurement, the Customer requires that the tenderer´s turnover each of the two (2) previous accounting years (2022 and 2023) have been at least one million euros (1 000 000 EUR).
Näytä lisää Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:
“Enrolment in a trade register: It is enrolled in the relevant trade registers kept in the Member State of its establishment.” Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“For further details please see the documents of the Call for tenders.” Osallistumisehdot
Poissulkemisperuste: bankr-nat
bankruptcy
corruption
cred-arran
crime-org
distorsion
envir-law
finan-laund
fraud
human-traffic
insolvency
labour-law
liq-admin
misrepresent
nati-ground
partic-confl
prep-confl
prof-misconduct
sanction
socsec-law
socsec-pay
susp-act
tax-pay
terr-offence
Kuvaus poissulkemisperusteista:
“The economic operator is in any analogous situation like bankruptcy arising from a similar procedure under national laws and regulations.”
“The economic operator is bankrupt.” Näytä lisää (22) “The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for corruption, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
“The economic operator is in arrangement with creditors.”
“The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for participation in a criminal organisation, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
“The economic operator has entered into agreements with other economic operators aimed at distorting competition.”
“The economic operator has breached its obligations in the field of environmental law.”
“The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for money laundering or terrorist financing, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
“The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for fraud, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
“The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for child labour and other forms of trafficking in human beings, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
“The economic operator is the subject of insolvency or winding-up.”
“The economic operator has breached its obligations in the field of labour law.”
“The assets of the economic operator are being administered by a liquidator or by the court.”
“The economic operator can confirm that:
a) It has been guilty of serious misrepresentation in supplying the information required for the verification of...”
Kuvaus poissulkemisperusteista
The economic operator can confirm that:
a) It has been guilty of serious misrepresentation in supplying the information required for the verification of the absence of grounds for exclusion or the fulfilment of the selection criteria,
b) It has withheld such information,
c) It has not been able, without delay, to submit the supporting documents required by a contracting authority or contracting entity, and
d) It has undertaken to unduly influence the decision making process of the contracting authority or contracting entity, to obtain confidential information that may confer upon it undue advantages in the procurement procedure or to negligently provide misleading information that may have a material influence on decisions concerning exclusion, selection or award.
“Any person who is a member of the economic operator’s administrative, management or supervisory body or has powers of representation, decision or control...”
Kuvaus poissulkemisperusteista
Any person who is a member of the economic operator’s administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for work safety offence, working hours offence, work discrimination, extortionate work discrimination, violation of the right to organise or unauthorised use of foreign labour.
“The economic operator is aware of any conflict of interest, as indicated in national law, the relevant notice or the procurement documents due to its...”
Kuvaus poissulkemisperusteista
The economic operator is aware of any conflict of interest, as indicated in national law, the relevant notice or the procurement documents due to its participation in the procurement procedure.
“The economic operator or an undertaking related to it has advised the contracting authority or contracting entity or otherwise been involved in the...”
Kuvaus poissulkemisperusteista
The economic operator or an undertaking related to it has advised the contracting authority or contracting entity or otherwise been involved in the preparation of the procurement procedure.
“The economic operator is guilty of grave professional misconduct.”
“The economic operator has experienced that a prior public contract, a prior contract with a contracting entity or a prior concession contract was terminated...”
Kuvaus poissulkemisperusteista
The economic operator has experienced that a prior public contract, a prior contract with a contracting entity or a prior concession contract was terminated early, or that damages or other comparable sanctions were imposed in connection with that prior contract.
“The economic operator has breached its obligations in the field of social law.”
“The economic operator has breached its obligations relating to the payment social security contributions, both in the country in which it is established and...”
Kuvaus poissulkemisperusteista
The economic operator has breached its obligations relating to the payment social security contributions, both in the country in which it is established and in Member State of the contracting authority or contracting entity if other than the country of establishment.
“The business activities of the economic operator are suspended.”
“The economic operator has breached its obligations relating to the payment of taxes, both in the country in which it is established and in Member State of...”
Kuvaus poissulkemisperusteista
The economic operator has breached its obligations relating to the payment of taxes, both in the country in which it is established and in Member State of the contracting authority or contracting entity if other than the country of establishment.
“The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision...”
Kuvaus poissulkemisperusteista
The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for terrorist offences or offences linked to terrorist activities, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.
Hankintaviranomainen Nimi ja osoitteet
Nimi: Finnish Institute for Health and Welfare
Kansallinen rekisterinumero: 2229500-6
Postiosoite: P. O. BOX 30
Postinumero: 00271
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Yhteyspiste: Procurement services / Keskitetty hankintatoimi
Sähköposti: kilpailutus@thl.fi📧
Puhelin: +358 295246000📞
URL: https://thl.fi/en/web/thlfi-en🌏 Hankintaviranomaisen tyyppi
Ministeriö tai muu kansallinen tai liittovaltiotason viranomainen
Päätoimi
Terveys
Viestintä
Osallistumisen URL-osoite: https://tarjouspalvelu.fi/thl?id=536840&tpk=837792eb-0ff8-46c6-9012-538f986d9c83🌏
EU:n rahoituksen tunniste: rescEU-MED-CBRN-FI
Lisätietoa EU-rahoituksesta:
“rescEU - Medical Stockpiling in Finland”
EU:n rahoitusohjelma: Unionin pelastuspalvelumekanismi (rescEU) (2021/2027)
Perustelut tiettyjen hankinta-asiakirjojen saatavuuden rajoittamiselle: Erityisen arkaluonteisten tietojen suojaaminen
Hankinta-asiakirjoihin pääsyä on rajoitettu
Tarjouksen/hakemuksen jättäminen sähköisesti: Pakollinen
Täydentävät tiedot Lisätietoja
“The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer...”
Lisätietoja
The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 6). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/5789/2.02.06/2024 / Antibacterials, antimycobacterials and antimycotics for systemic use, part 2". The message shall contain name of the tenderer and email address to which the Annex 7 is to be sent.
Näytä lisää Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi📧
Puhelin: +358 295643300📞
URL: http://www.oikeus.fi/markkinaoikeus🌏 Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Sähköistä maksua käytetään
Lähde: OJS 2024/S 248-782887 (2024-12-18)
Ilmoitus tehdystä sopimuksesta (2025-09-22) Kohde Hankinnan laajuus
Otsikko: Clindamycin 150 mg/ml (4ml per vial/ampoule)
Viitenumero: THL/1433/2.02.06/2025
Lyhyt kuvaus:
“Hankinnan kohteena on Clindamycin 150 mg/ml (4 ml per vial/ampoule) (myöhemmin ’Clindamycin-valmiste’). Kyseessä on kertahankinta ja tuote tulee Suomen...”
Lyhyt kuvaus
Hankinnan kohteena on Clindamycin 150 mg/ml (4 ml per vial/ampoule) (myöhemmin ’Clindamycin-valmiste’). Kyseessä on kertahankinta ja tuote tulee Suomen rescEU Medical -varastointihankkeen käyttöön. Arvioidun määrän lisäksi THL:lla on oikeus ostaa tuotetta 100 % arvioidun määrän lisäksi ("Optio"). Hankinnan kokonaisarvo on 618 000 euroa Optiot mukaan lukien. Hankintayksikkö hankkii lääkevalmistetta hankintalain mukaisena suorahankintana valitulta toimittajalta. Aiemmassa avoimessa menettelyssä ei ole saatu lainkaan tarjouksia ja alkuperäisiä tarjouspyynnön ehtoja ei olennaisesti muuteta.
Näytä lisää
Tuotteet/palvelut: Systeemiset bakteerilääkkeet📦
EU:n rahoittaman hankkeen tai ohjelman nimi: Unionin pelastuspalvelumekanismi (rescEU) (2021/2027)
Lisätietoa EU-rahoituksesta:
“rescEU - Medical Stockpiling in Finland”
EU:n rahoituksen tunniste: rescEU-MED-CBRN-FI
Kuvaus
Sisäinen tunniste: THL/1433/2.02.06/2025
Hankinnan kuvaus:
“Hankinnan kohteena on Clindamycin 150 mg/ml (4 ml per vial/ampoule) (myöhemmin ’Clindamycin-valmiste’). Kyseessä on kertahankinta ja tuote tulee Suomen...”
Hankinnan kuvaus
Hankinnan kohteena on Clindamycin 150 mg/ml (4 ml per vial/ampoule) (myöhemmin ’Clindamycin-valmiste’). Kyseessä on kertahankinta ja tuote tulee Suomen rescEU Medical -varastointihankkeen käyttöön. Arvioidun määrän lisäksi THL:lla on oikeus ostaa tuotetta 100 % arvioidun määrän lisäksi ("Optio"). Hankinnan kokonaisarvo on 618 000 euroa Optiot mukaan lukien. Hankintayksikkö hankkii lääkevalmistetta hankintalain mukaisena suorahankintana valitulta toimittajalta. Aiemmassa avoimessa menettelyssä ei ole saatu lainkaan tarjouksia ja alkuperäisiä tarjouspyynnön ehtoja ei olennaisesti muuteta.
Näytä lisää
Lisätuotteet/palvelut: Farmaseuttiset tuotteet📦 Myöntämisperusteet
Hinta (painotus): 100
Otsikko
Erän tunnistenumero: LOT-0000
Menettely Toimenpiteen tyyppi
Neuvottelumenettely ilman edeltävää tarjouskilpailua ✅ Hankintasopimuksen tekeminen julkaisematta etukäteen kilpailupyyntöä Euroopan unionin virallisessa lehdessä seuraavissa tapauksissa
Ei tarjouksia tai sopivia tarjouksia/hakemuksia ✅ Toimenpiteen tyyppi
Hankintasopimuksen tekeminen julkaisematta etukäteen kilpailupyyntöä Euroopan unionin virallisessa lehdessä (selitys):
“Lain julkisista hankinnoista ja käyttöoikeussopimuksista (1397/2016, myöhemmin ’hankintalaki’) 40 §:n 2 momentin 1 kohdan nojalla hankintayksikkö voi valita...”
Hankintasopimuksen tekeminen julkaisematta etukäteen kilpailupyyntöä Euroopan unionin virallisessa lehdessä (selitys)
Lain julkisista hankinnoista ja käyttöoikeussopimuksista (1397/2016, myöhemmin ’hankintalaki’) 40 §:n 2 momentin 1 kohdan nojalla hankintayksikkö voi valita suorahankinnan, jos avoimessa tai rajoitetussa menettelyssä ei ole saatu lainkaan osallistumishakemuksia tai tarjouksia taikka soveltuvia osallistumishakemuksia tai tarjouksia; lisäedellytyksenä on, että alkuperäisiä tarjouspyynnön ehtoja ei olennaisesti muuteta.
Hankintayksikkö aloitti Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01) (myöhemmin ’Clindamycin-valmiste’) hankinnan hankintalain 32 §:n mukaista avointa hankintamenettelyä noudattaen osana ”Antibacterials, antimycobacterials and antimycotics for systemic use, part 2” -hankintakokonaisuutta (LOT 3). Hankintayksikkö julkaisi hankintaa koskevan hankintailmoituksen HILMA-tietokannassa 20.12.2024 (ilmoituksen numero: 2024-018322) sekä TED-tietokannassa (ilmoituksen numero 782887-2024) 20.12.2024. Tarjousten viimeinen jättöajankohta oli 5.2.2025 klo 12 Suomen aikaa. Hankintayksikkö ei saanut Clindamycin-valmisteesta tarjousaikana lainkaan tarjouksia. Hankintayksikkö ei muuta suorahankintaa edeltäneessä avoimessa menettelyssä julkaistussa tarjouspyynnössä hankinnankohteelle asetettuja minimivaatimuksia tai hankintasopimusluonnosta.
Edellä mainituilla perusteilla hankintayksikkö hankkii Clindamycin-valmistetta hankintalain mukaisena suorahankintana MIP Pharma GmbH:lta. Avoimessa menettelyssä ei ole saatu lainkaan tarjouksia ja alkuperäisiä tarjouspyynnön ehtoja ei olennaisesti muuteta.
Näytä lisää Myöntämisperusteet
Kiintolukutyyppi: Kiinteä arvo (yhteensä)
Sopimuksen tekeminen
Erän tunnistenumero: LOT-0000
Sopimuksen numero: THL/1433/2.02.06/2025
Tarjouksen tunniste: THL/1433/2.02.06/2025
Osan tai osien ryhmän tunniste: LOT-0000
Toimeksisaajan nimi ja osoite
Nimi: MIP Pharma Holding GmbH
Kansallinen rekisterinumero: DEHRB106942
Postiosoite: Technologiepark 5
Postinumero: 66424
Postitoimipaikka: Homburg
Alue: Saarpfalz-Kreis 🏙️
Maa: Saksa 🇩🇪
Sähköposti: info@mip-pharma.de📧
Puhelin: +49684296090📞
Organisaation koko: Keskisuuri
Hankintaviranomainen Nimi ja osoitteet
Nimi: Terveyden ja hyvinvoinnin laitos
Postiosoite: PL 30
Yhteyspiste: Keskitetty hankintatoimi
URL: http://www.thl.fi/🌏 Viestintä
Edellisen ilmoituksen tunniste: 782887-2024
Lähde: OJS 2025/S 182-620219 (2025-09-22)
Ilmoitus tehdystä sopimuksesta (2025-11-17) Kohde Hankinnan laajuus
Hankinnan kokonaisarvo (ilman arvonlisäveroa): 618 000 EUR 💰
Kuvaus
Lisätietoja:
“Hankintaa ei ole jaettu eri osiin, koska hankinnan kohteena on yksi tuote, eikä hankinnan jakaminen eri osiin ole tarkoituksenmukaista sen kokonaisuuden ja...”
Lisätietoja
Hankintaa ei ole jaettu eri osiin, koska hankinnan kohteena on yksi tuote, eikä hankinnan jakaminen eri osiin ole tarkoituksenmukaista sen kokonaisuuden ja tarkoituksen huomioon ottaen. Hankinnan jakaminen osiin ei ole tarkoituksenmukaista eikä se tuota lisäarvoa hankinnalle.
Sopimuksen tekeminen
Sopimus/erä myönnetään ✅
Sopimuksen tekopäivä: 2025-11-08 📅
Tietoa tarjouskilpailuista
Muista EU:n jäsenvaltioista tulevilta tarjoajilta saatujen tarjousten määrä: 1
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: 618 000 EUR 💰
Täydentävät tiedot Lisätietoja
“Hankintaa ei ole jaettu eri osiin, koska hankinnan kohteena on yksi tuote, eikä hankinnan jakaminen eri osiin ole tarkoituksenmukaista sen kokonaisuuden ja...”
Lisätietoja
Hankintaa ei ole jaettu eri osiin, koska hankinnan kohteena on yksi tuote, eikä hankinnan jakaminen eri osiin ole tarkoituksenmukaista sen kokonaisuuden ja tarkoituksen huomioon ottaen. Hankinnan jakaminen osiin ei ole tarkoituksenmukaista eikä se tuota lisäarvoa hankinnalle.
Näytä lisää Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):
“Hankintayksikkö on toimittanut julkaistavaksi hankintalain 131 §:ssä tarkoitetun suorahankintaa koskevan ilmoituksen Euroopan unionin virallisessa lehdessä....”
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista)
Hankintayksikkö on toimittanut julkaistavaksi hankintalain 131 §:ssä tarkoitetun suorahankintaa koskevan ilmoituksen Euroopan unionin virallisessa lehdessä. Valitus on tehtävä 14 päivän kuluessa ilmoituksen julkaisemisesta.
Näytä lisää
Lähde: OJS 2025/S 222-764318 (2025-11-17)